{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:26:03Z","timestamp":1793399163736,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92861-5","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:43:20Z","timestamp":1744476200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection"],"prefix":"10.1038","volume":"15","author":[{"given":"Dominik","family":"Pruski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Millert-Kali\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"92861_CR1","doi-asserted-by":"crossref","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.. 74(3):229\u2013263. (2024).","DOI":"10.3322\/caac.21834"},{"issue":"5","key":"92861_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5603\/gpl.96712","volume":"95","author":"D Pruski","year":"2024","unstructured":"Pruski, D., Millert-Kalinska, S., Klemenska, P., Jach, R. & Przybylski, M. Clinical use of the onclarity test with extended HPV genotyping and phenotyping in patients with suspected squamous intraepithelial lesions. Ginekol. Pol. 95 (5), 328\u2013334. https:\/\/doi.org\/10.5603\/gpl.96712 (2024).","journal-title":"Ginekol. Pol."},{"key":"92861_CR3","doi-asserted-by":"publisher","first-page":"27220","DOI":"10.1038\/s41598-024-78773-w","volume":"14","author":"F Xiao","year":"2024","unstructured":"Xiao, F. & Sui, L. Evaluation of a real-time optoelectronic method for the detection of cervical intraepithelial neoplasia and cervical cancer in patients with different transformation zone types. Sci. Rep. 14, 27220. https:\/\/doi.org\/10.1038\/s41598-024-78773-w (2024).","journal-title":"Sci. Rep."},{"key":"92861_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41746-022-00559-z","volume":"5","author":"P Xue","year":"2022","unstructured":"Xue, P. et al. Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis. Npj Digit. Med. 5, 19. https:\/\/doi.org\/10.1038\/s41746-022-00559-z (2022).","journal-title":"Npj Digit. Med."},{"issue":"4","key":"92861_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/ijgc-2022-004213","volume":"33","author":"V Kesic","year":"2023","unstructured":"Kesic, V. et al. The European society of gynaecological oncology (ESGO), the international society for the study of vulvovaginal disease (ISSVD), the European college for the study of vulval disease (ECSVD), and the European federation for colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia. Int. J. Gynecol. Cancer. 33 (4), 446\u2013461. https:\/\/doi.org\/10.1136\/ijgc-2022-004213 (2023).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"92861_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ijc.32126","volume":"145","author":"J Pan","year":"2019","unstructured":"Pan, J. et al. Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease. Int. J. Cancer. 145, 427\u2013434 (2019).","journal-title":"Int. J. Cancer"},{"key":"92861_CR7","doi-asserted-by":"publisher","first-page":"f7361","DOI":"10.1136\/bmj.f7361","volume":"348","author":"B Strander","year":"2014","unstructured":"Strander, B., H\u00e4llgren, J. & Spar\u00e9n, P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. BMJ 348, f7361 (2014).","journal-title":"BMJ"},{"key":"92861_CR8","unstructured":"European Medicines Agency (EMA). Gardasil 9 Summary of Product Characteristics, https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/gardasil-9-epar-product-information_en.pdf  (Accessed 9 Sep  2020). (2020)."},{"key":"92861_CR9","unstructured":"Merck, Sharp, Dohme, L. L. C., Rahway, N. J. & Gardasil\u00ae9, U. S. A. US Prescribing Information, https:\/\/www.merck.com\/product\/usa\/pi_circulars\/g\/gardasil_9\/gardasil_9_pi.pdf, (Accessed 9 Apr  2023). (2023)."},{"key":"92861_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1186\/s12885-020-07452-6","volume":"20","author":"M Preti","year":"2020","unstructured":"Preti, M. et al. Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia. BMC Cancer. 20, 972. https:\/\/doi.org\/10.1186\/s12885-020-07452-6 (2020).","journal-title":"BMC Cancer"},{"key":"92861_CR11","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2016","volume":"35","author":"MF Rene \u0301e","year":"2017","unstructured":"Rene \u0301e, M. F. et al. Long-Lasting increased risk of human Papillomavirus\u2013Related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: A Population-Based cohort study. J. Clin. Oncol. 35, 2542\u20132550. https:\/\/doi.org\/10.1200\/JCO.2016 (2017).","journal-title":"J. Clin. Oncol."},{"key":"92861_CR12","doi-asserted-by":"publisher","first-page":"e070135","DOI":"10.1136\/bmj-2022-070135","volume":"378","author":"KS Kechagias","year":"2022","unstructured":"Kechagias, K. S. et al. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis. BMJ 378, e070135. https:\/\/doi.org\/10.1136\/bmj-2022-070135 (2022).","journal-title":"BMJ"},{"key":"92861_CR13","doi-asserted-by":"publisher","unstructured":"Joura, E. A. et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of threerandomizedd clinical trials. Lancet 369(9574):1693\u2009-1702.https:\/\/doi.org\/10.1016\/S0140-6736(07)60777-6. (2007).","DOI":"10.1016\/S0140-6736(07)60777-6"},{"issue":"7","key":"92861_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djaa209","volume":"113","author":"C Dehlendorff","year":"2021","unstructured":"Dehlendorff, C., Baandrup, L. & Kjaer, S. K. Real-World effectiveness of human papillomavirus vaccination against vulvovaginal High-Grade precancerous lesions and cancers. J. Natl. Cancer Inst. 113 (7), 869\u2013874. https:\/\/doi.org\/10.1093\/jnci\/djaa209 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"92861_CR15","doi-asserted-by":"publisher","first-page":"909223","DOI":"10.3389\/fcimb.2022.909223","volume":"12","author":"Y Mo","year":"2022","unstructured":"Mo, Y. et al. Prophylactic and therapeutic HPV vaccines: current scenario and perspectives. Front. Cell. Infect. Microbiol. 12, 909223 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"92861_CR16","doi-asserted-by":"publisher","unstructured":"Eerkens, A. L. et al. Vvax001, a therapeutic vaccine for patients with HPV16-positive High-grade cervical intraepithelial neoplasia: a phase II trial. Clin. Cancer Res.  https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1662 (2025).","DOI":"10.1158\/1078-0432.CCR-24-1662"},{"issue":"24","key":"92861_CR17","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.3390\/jcm12247592","volume":"12","author":"D Pruski","year":"2023","unstructured":"Pruski, D. et al. Effect of HPV vaccination on virus disappearance in cervical samples of a cohort of HPV-Positive Polish patients. J. Clin. Med. 12 (24), 7592. https:\/\/doi.org\/10.3390\/jcm12247592 (2023).","journal-title":"J. Clin. Med."},{"issue":"42","key":"92861_CR18","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1016\/j.vaccine.2023.08.047","volume":"41","author":"M Reuschenbach","year":"2023","unstructured":"Reuschenbach, M. et al. Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer. Vaccine 41 (42), 6194\u20136205 (2023).","journal-title":"Vaccine"},{"key":"92861_CR19","doi-asserted-by":"publisher","first-page":"e1401","DOI":"10.1136\/bmj.e1401","volume":"344","author":"EA Joura","year":"2012","unstructured":"Joura, E. A. et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 344, e1401 (2012).","journal-title":"BMJ"},{"key":"92861_CR20","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/jsm.12670","volume":"11","author":"ER Coskuner","year":"2014","unstructured":"Coskuner, E. R., Ozkan, T. A., Karakose, A., Dillioglugil, O. & Cevik, I. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV infection: arandomizedd study. J. Sex. Med. 11, 2785\u20132791 (2014).","journal-title":"J. Sex. Med."},{"issue":"2","key":"92861_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/vaccines9020083","volume":"9","author":"A Ghelardi","year":"2021","unstructured":"Ghelardi, A. et al. Surgical treatment of vulvar HSIL: adjuvant HPV vaccine reduces recurrent disease. Vaccines (Basel). 9 (2), 83. https:\/\/doi.org\/10.3390\/vaccines9020083 (2021).","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"92861_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/aogs.14359","volume":"101","author":"DO Eriksen","year":"2022","unstructured":"Eriksen, D. O., Jensen, P. T., Schroll, J. B. & Hammer, A. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 101 (6), 597\u2013607. https:\/\/doi.org\/10.1111\/aogs.14359 (2022).","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"92861_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/vaccines10020239","volume":"10","author":"V Di Donato","year":"2022","unstructured":"Di Donato, V. et al. HPV vaccination after primary treatment of HPV-Related disease across different organ sites: A multidisciplinary comprehensive review and Meta-Analysis. Vaccines (Basel). 10 (2), 239. https:\/\/doi.org\/10.3390\/vaccines10020239 (2022).","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"92861_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/LGT.0000000000000703","volume":"27","author":"KE Sharpless","year":"2023","unstructured":"Sharpless, K. E., Marcus, J. Z., Kuroki, L. M., Wiser, A. L. & Flowers, L. ASCCP committee opinion: adjuvant human papillomavirus vaccine for patients undergoing treatment for cervical intraepithelial neoplasia. J. Low Genit. Tract. Dis. 27 (1), 93\u201396. https:\/\/doi.org\/10.1097\/LGT.0000000000000703 (2023).","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"5","key":"92861_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/vaccines10050728","volume":"10","author":"D Pruski","year":"2022","unstructured":"Pruski, D. et al. Immunity after HPV vaccination in patients after sexual initiation. Vaccines (Basel). 10 (5), 728. https:\/\/doi.org\/10.3390\/vaccines10050728 (2022).","journal-title":"Vaccines (Basel)"}],"updated-by":[{"DOI":"10.1038\/s41598-025-02469-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92861-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:57:04Z","timestamp":1749621424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92861-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92861-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4594994\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-02469-y","URL":"https:\/\/doi.org\/10.1038\/s41598-025-02469-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12642"}}